Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers

Eitemau Tebyg

• A call for better reporting of trials using surrogate primary endpoints
  gan: Anthony Muchai Manyara, et al.
  Cyhoeddwyd: (2022-01-01)
• Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol
  gan: Derek Stewart, et al.
  Cyhoeddwyd: (2022-10-01)
• Surrogate endpoints in trials: a call for better reporting
  gan: Oriana Ciani, et al.
  Cyhoeddwyd: (2022-12-01)
• Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
  gan: Martin Offringa, et al.
  Cyhoeddwyd: (2022-10-01)
• Biomarkers and surrogate endpoints.
  gan: Aronson, J
  Cyhoeddwyd: (2005)